TrialDiabetologia2017

Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial.

Christoph Kapitza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.